BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  EnGeneIC Wins Innovation Award from Australian Financial Review

  Named Most Innovative Healthcare Company of 2019 for its Nanocell Platform for Targeted Cyto-Immunotherapy in Cancer Treatment

  August 9, 2019

   · 

  4 min read
• Policy

  OssDsign AB (publ) Initiates Commercial Preparations for Launch in Japan Following Regulatory Filing for OssDsign Cranial

  OssDsign AB, the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a Japanese regulatory approval of OssDsign Cranial.

  August 9, 2019

   · 

  3 min read
• Policy

  /R E P E A T -- Notice to the Media - Health Canada Officials Will Provide an Update on Important Steps Toward National Pharmacare/

  Health Canada officials will provide an update on important steps toward National Pharmacare.

  August 9, 2019

   · 

  1 min read
• Job Trends

  New Academic Delphi Panel Formed to Define Best Practices for Using Bone Marrow Concentrate

  A nationwide panel of experts are using the Delphi consensus building method, developed by the RAND Corporation, to drive consensus and guidelines on the procedural use of bone marrow concentrate

  August 9, 2019

   · 

  2 min read
• Deals

  Innovus Pharmaceuticals to Release Second Quarter 2019 Financial Results and Provide Corporate Update on Tuesday, August 13, 2019

  Innovus Pharmaceuticals, Inc. announced that the Company will release its second quarter 2019 financial results and provide a corporate update on Tuesday, August 13, 2019, after the close of the U.S. financial markets.

  August 9, 2019

   · 

  3 min read
• Business

  Epizyme Reports Business Progress and Second Quarter 2019 Results

  Epizyme, Inc., a late-stage biopharmaceutical company developing novel epigenetic therapies, provided business and pipeline highlights and reported second quarter 2019 financial results.

  August 9, 2019

   · 

  9 min read
• Deals

  Cipher Pharmaceuticals Reports Second Quarter 2019 Financial Results

  Cipher Pharmaceuticals Inc. announced its financial and operating results for the three months ended June 30, 2019.

  August 9, 2019

   · 

  10 min read
• Business

  Intec Pharma Reports Second Quarter 2019 Financial Results and Business Update

  Intec Pharma Ltd. announces financial results for the three and six months ended June 30, 2019.

  August 9, 2019

   · 

  10 min read
• Business

  Leap Therapeutics Reports Second Quarter 2019 Financial Results

  Leap Therapeutics, Inc. reported financial results for the second quarter ended June 30, 2019.

  August 9, 2019

   · 

  8 min read
• Business

  CASI Pharmaceuticals Announces Second Quarter and First Half 2019 Financial and Business Results

  CASI Pharmaceuticals, Inc. reported financial results for the second quarter and six months ended June 30, 2019 and provided a review of recent accomplishments and anticipated milestones.

  August 9, 2019

   · 

  8 min read